David A. Morgott

Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations

Raymond M. David, Harvey J. Clewell, P. Robinan Gentry et al. · Regulatory Toxicology and Pharmacology · 2006 · 52 citations

Epidemiology, Cancer Risk, Cancer Epidemiology +15

Revised assessment of cancer risk to dichloromethane: Part I Bayesian PBPK and dose–response modeling in mice

Dale J. Marino, Harvey J. Clewell, P. Robinan Gentry et al. · Regulatory Toxicology and Pharmacology · 2006 · 48 citations

Cancer Risk, Pharmacokinetic Modeling, Cancer Epidemiology +10

Development of a Physiologically Based Pharmacokinetic Model for Hydroquinone

Richard Corley, J. Caroline English, T.S. Hill et al. · Toxicology and Applied Pharmacology · 2000 · 28 citations

Pharmacokinetic Modeling, Pharmacodynamics, Pharmacological Study +7

Nonlinear kinetics of inhaled propylene glycol monomethyl ether in Fischer 344 rats following single and repeated exposures

David A. Morgott, R.J. Nolan · Toxicology and Applied Pharmacology · 1987 · 19 citations

Respiratory Toxicology, Medicine, Physiology +9

Estimation of interindividual variation in oxidative metabolism of dichloromethane in human volunteers

Lisa Sweeney, Christopher R. Kirman, David A. Morgott et al. · Toxicology Letters · 2004 · 16 citations

Oxidative Metabolism, Biochemistry, Physiology +12